BLS tracks a representative sample of prescription drug costs on the market, measuring the actual amount people pay for the drugs, not list prices, according to Business Insider.
While healthcare experts cannot confidently identify the reason behind this spike, Yale economist Fiona Scott Morton, PhD, believes pricey biologic drugs may be fueling costs, reports Marketplace.
More articles on supply chain:
Tenn. high school opens medical device machinery lab
Sen. Blumenthal urges DOJ to reject Mylan settlement
TPC names ROi preferred supply chain partner: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
